RT Book, Section
A1 Atkinson, Holly G.
A2 Fuster, Valentin
A2 Harrington, Robert A.
A2 Narula, Jagat
A2 Eapen, Zubin J.
SR Print(0)
ID 1192038860
T1 SOCIAL DETERMINANTS OF CARDIOVASCULAR DISEASE
T2 Hurst's The Heart, 14e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071843249
LK accesscardiology.mhmedical.com/content.aspx?aid=1192038860
RD 2024/04/18
AB Cardiovascular  disease  (CVD)  is  the  number  one  cause  of  death  around  the  globe,  now  accounting  for  about  one  in  three  deaths.1  More  than  80%  of  these  CVD  deaths  take  place  in  low-  and  middle-income  countries.2  Although  mortality  from  CVD  in  the  United  States  has  been  declining  since  the  1970s,  heart  disease  is  still  the  leading  cause  of  death  in  America  as  well,  accounting  for  approximately  31.3%  of  deaths  in  2011.3  The  US  decline  in  CVD  mortality  has  been  attributed  to  advances  in  prevention,  diagnosis,  and  treatment.  However,  if  current  trends  prevail,  the  prevalence  of  CVD  in  the  United  States  is  expected  to  rise  10%  between  2010  and  2030.4  This  projected  rise  in  CVD  prevalence  is  attributed  to  a  number  of  factors:  an  aging  populace,  an  increase  in  major  risk  factors  (hypertension,  lack  of  physical  activity,  obesity,  and  diabetes),  and  growing  socioeconomic  inequality  that  accentuate  the  deleterious  social  determinants  of  health.  Further,  the  clinical  advances  made  in  the  diagnosis,  treatment,  and  prevention  of  CVD  have  not  been  equally  available  to  all  individuals  throughout  our  society.5  The  United  States  is  one  of  the  richest  nations  in  the  world  and  spends  more  per  capita  on  health  care  than  any  other  nation,  and  yet  America  has  one  of  the  shortest  life  expectancies  at  birth  of  any  industrialized  nation,  ranking  27th  out  of  34  Organization  for  Economic  Cooperation  and  Development  countries.6